Dry Eye Disease

Okyo Pharma has announced additional findings from its phase 2 trial of OK-101, including statistically significant improvement in ocular pain relief, conjunctival staining and tear breakup time in patients with dry eye disease.

There are many different types of dry eye disease clinics in North America. No matter what type of practice you might have, it is highly likely that practicing your subspecialty became measurably easier in 2023.

A water-free cyclosporine 0.1% solution demonstrated superiority over vehicle in corneal fluorescein staining among adults with moderate to severe dry eye disease, according to a study conducted in China and published in JAMA Ophthalmology.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Karl G. Stonecipher, MD, discusses newer treatments and thought processes in diagnostics in artificial intelligence in dry eye disease.

ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.

ATLANTA —There is limited evidence to show that LipiFlow is more effective than commonly used treatments for dry eye disease and meibomian gland dysfunction, according to recently published research.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Rahim Hirji, RPh, describes the products available from Verséa Ophthalmics.

There are two areas I am really excited about specifically in the areas of lid margin disease and dry eye disease.

In dry eye care, 2023 was a year of substantial changes, and ophthalmologists and their patients have welcomed more treatment options that bring relief.